Natixis
- SEC CIK
- 0001274981
- Latest filing
- Aug 13, 2026
RDY holding history
Dr Reddys Laboratories Ltd in every 13F filed by Natixis, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RDY overviewAll 13F holders of RDYFull Q2 2026 holdings
- Shares (Q2 2026)
- 726
- Value
- $10.5K
- % of portfolio
- <0.1%
- Quarters held
- 14
- Since Q1 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 726 | $10.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 726 | $10.1K | <0.1% | +61+9.2% | Added | Holders |
| Q4 2025 | 665 | $9.34K | <0.1% | +46+7.4% | Added | Holders |
| Q3 2025 | 619 | $8.65K | <0.1% | −3,302−84.2% | Reduced | Holders |
| Q2 2025 | 3,921 | $58.9K | <0.1% | −102−2.5% | Reduced | Holders |
| Q1 2025 | 4,023 | $53.0K | <0.1% | −332−7.6% | Reduced | Holders |
| Q4 2024 | 4,355 | $68.8K | <0.1% | 00.0% | UnchangedConverted for a 5-for-1 split | Holders |
| Q3 2024 | 871 | $69.2K | <0.1% | +304+53.6% | Added | Holders |
| Q2 2024 | 567 | $43.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 567 | $41.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 567 | $39.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 567 | $37.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 567 | $35.8K | <0.1% | −144−20.3% | Reduced | Holders |
| Q1 2023 | 711 | $40.5K | <0.1% | +711 | New | Holders |